The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Electronic patient-reported outcome measures (E-Proms): Results of the H2020 CAPABLE project for patients with metastatic renal cell cancer (mRCC).
 
Laura D. Locati
Honoraria - Bayer; Eisai; Gentili SrL; Ipsen; Lilly; MSD Oncology; Roche; Seagen; Sun Pharma
Consulting or Advisory Role - Eisai; Lilly; MSD; Novartis
Research Funding - MSD Oncology (Inst)
Travel, Accommodations, Expenses - Gilead Sciences
 
Mimma Rizzo
Honoraria - Janssen Oncology; MSD
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen Oncology; Merck Serono; MSD Oncology
Speakers' Bureau - MSD Oncology
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst); Roche (Inst)
Expert Testimony - MSD Oncology
 
Paola Gabanelli
No Relationships to Disclose
 
Silvana Quaglini
No Relationships to Disclose
 
Valentina Tibollo
No Relationships to Disclose
 
Alberto Malovini
No Relationships to Disclose
 
Silvia Panzarasa
No Relationships to Disclose
 
Matteo Terzaghi
No Relationships to Disclose
 
Giordano Lanzola
No Relationships to Disclose
 
Andrea Premoli
No Relationships to Disclose
 
Sara Demurtas
No Relationships to Disclose
 
Lucia Sacchi
No Relationships to Disclose